 |
|
| 3WIN | | 3WIN is an early stage venture in the active implantable medical device industry.
The company is pursuing to add high-tech innovative solutions to the field.
The founders of 3WIN have been pioneers in the cochlear implant industry.
The 3WIN-team consists of highly trained and experienced R&D and production engineers, clinical and marketing experts.
3WIN has an on-site-state-of-the-art workshop and clean room, with high tech equipment, for development and production of active  |
|
|
|
| AnSem | | Based in Leuven, Belgium, AnSem is a fabless IC design house founded in 1998 specializing in the development of the most advanced analog and mixed-signal integrated circuits for RF CMOS, high-speed data communication, data acquisition and ultra low-power & low-voltage applications.
AnSem is a proven and solid development partner worldwide for customers requiring custom design, IP based design and full turnkey solutions. |
|
|
|
|
|
|
|
| eSaturnus | | | eSaturnus is an advanced technology provider for digital signal processing and multimedia solutions within and beyond modern operating rooms. |
|
|
|
| Gent BC | | Gent BC (Big in Creativity) is an online and real life network fostering knowledge based industry, entrepreneurship and innovation in the region of Ghent.
On-line network: via the website you will have access to news and events related to innovation and knowledge based industries in the region of Ghent.
Real-life network: Gent BC organises networking events around innovation and entrepreneurship. |
|
|
|
|
|
| ICsense | | ICsense is an ISO 9001:2000 certified IC design house, specialized in analog, mixed-signal and high-voltage IC design services and ASIC turnkey solutions.
ICsense provides best-in-class IC design services from consultancy and building block design up to complete mixed-signal ASICs or SoCs.
ICsense offers customer-specific ASIC turnkey solutions, from idea to final product, beyond existing solutions in the market. ICsense manages the complete design of production-ready ICs, production test |
|
|
|
| imec | | | Imec performs world-leading research in nanoelectronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. |
|
|
|
| Inforstat | | Statistical treatment is an instrument contributing to the right decision in the realization of your projects.
Inforstat, a company specialized in statistical consulting, helps you designing your experiments or surveys, organizes your data, presents and analyses those with the most appropriate statistical methods.
|
|
|
|
|
|
| Materialise nv | | | With its headquarters in Leuven, Belgium and branches all over the world, the Materialise Group is best known for its activities in the field of rapid industrial and medical prototyping. Apart from having the largest capacity of rapid prototyping equipment in Europe, Materialise enjoys a worldwide reputation as provider of innovative software solutions. As such, Materialise has acquired the position of market leader for 3D printing and Digital CAD software in addition to being a major player in |
|
|
|
| Mobelife | | | Mobelife provides complete tailor made orthopedic solutions. Its focus is on the design of innovative patient specific bone and joint replacement. |
|
|
|
|
|
| reMYND NV | | reMYND actively drives the development of disease modifying treatments against Alzheimer's Disease (AD) and Parkinson's Disease (PD), either as a Contract Research Organisation (CRO) or through its own Drug Discovery&Development.
|
|
|
|
| ThromboGenics NV | | | ThromboGenics is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company has used its in house expertise to build a significant pipeline of promising drug candidates, a number of which are in clinical trials. The Company is focused on developing new medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system. ThromboGenics' lead product is |
|
|
|
| Tigenix | | TiGenix is a public listed, late-stage biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. Based in Leuven, Belgium, TiGenix was founded in 2000 as a spin-off from the the Katholieke Universiteit Leuven and the Universiteit Gent.
|
|
|
Contact